We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
Cap. Flow
-$198M
Cap. Flow %
-15.04%
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$9.86M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$9.7M
3
CNR
Core Natural Resources Inc
CNR
+$8.26M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$6.63M
5
ORCL icon
Oracle
ORCL
+$6.25M

Top Sells

Rank Stock Value
1
SMAR
Smartsheet Inc.
SMAR
+$14M
2
HTLF
Heartland Financial USA, Inc.
HTLF
+$11.1M
3
NVDA icon
NVIDIA
NVDA
+$9.36M
4
AMZN icon
Amazon
AMZN
+$8.75M
5
NFLX icon
Netflix
NFLX
+$8.58M

Sector Composition

Rank Sector Weight
1 Technology 13.2%
2 Healthcare 10.48%
3 Consumer Discretionary 9.93%
4 Financials 7.26%
5 Communication Services 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OKTA icon
426
Okta
OKTA
$26.5B
$653K 0.05%
+6,206
New +$606K
FLG
427
Flagstar Bank National Association
FLG
$5.83B
$653K 0.05%
56,168
-98,944
-64% -$1.11M
PRGS icon
428
Progress Software
PRGS
$1.78B
$652K 0.05%
+12,660
New +$725K
JNJ icon
429
Johnson & Johnson
JNJ
$624B
$651K 0.05%
3,928
+786
+25% +$123K
SU icon
430
Suncor Energy
SU
$73.6B
$649K 0.05%
16,758
+673
+4% +$25.7K
SAP icon
431
SAP
SAP
$240B
$644K 0.05%
+2,400
New +$654K
TVTX icon
432
Travere Therapeutics
TVTX
$5.77B
$643K 0.05%
+35,909
New +$729K
RRC icon
433
Range Resources
RRC
$9.41B
$643K 0.05%
16,100
– –
ELV icon
434
Elevance Health
ELV
$85.9B
$639K 0.05%
+1,470
New +$590K
CRWV
435
CoreWeave
CRWV
$48.6B
$639K 0.05%
+17,231
New +$664K
PKG icon
436
Packaging Corp of America
PKG
$22.6B
$633K 0.05%
3,197
+240
+8% +$51.2K
INTR icon
437
Inter&Co
INTR
$2.37B
$630K 0.05%
115,000
+91,000
+379% +$473K
CMC icon
438
Commercial Metals
CMC
$8.14B
$629K 0.05%
13,675
+5,586
+69% +$272K
HBM icon
439
Hudbay
HBM
$12.3B
$626K 0.05%
82,436
+5,291
+7% +$43.1K
CTVA icon
440
Corteva
CTVA
$51.2B
$624K 0.05%
9,908
-118,564
-92% -$7.33M
MMYT icon
441
MakeMyTrip
MMYT
$5.7B
$621K 0.05%
6,336
+3,536
+126% +$365K
EOG icon
442
EOG Resources
EOG
$74.5B
$615K 0.05%
4,799
-819
-15% -$105K
EWW icon
443
iShares MSCI Mexico ETF
EWW
$1.91B
$614K 0.05%
12,043
+43
+0.4% +$2.17K
XENE icon
444
Xenon Pharmaceuticals
XENE
$6.14B
$613K 0.05%
18,266
– –
CRDO icon
445
Credo Technology Group
CRDO
$45.8B
$610K 0.05%
15,182
+10,182
+204% +$633K
GDEN
446
DELISTED
Golden Entertainment
GDEN
$607K 0.05%
23,017
+33
+0.1% +$1.02K
VRP icon
447
Invesco Variable Rate Preferred ETF
VRP
$3.02B
$606K 0.05%
+25,000
New +$608K
PCRX icon
448
Pacira BioSciences
PCRX
$976M
$605K 0.05%
24,339
+4,804
+25% +$115K
BTU icon
449
Peabody Energy
BTU
$3B
$601K 0.05%
44,369
+17,103
+63% +$275K
DTE icon
450
DTE Energy
DTE
$28.6B
$600K 0.05%
+4,338
New +$554K
16 17
18
19 20

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.

  • Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
  • Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
  • Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
  • Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
  • Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
  • Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
  • Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.

Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.